Elizabeth Yeu Lin - Chief Medical Officer at Tarsus Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Stock Symbol
TARS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Elizabeth Yeu Lin - trading volume in the past year for Tarsus Pharmaceuticals, Inc.

Holdings reported by Elizabeth Yeu Lin for Tarsus Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 15.9K $751K $47.36 Jun 13, 2025 By Spouse's Roth IRA
Common Stock 12K $570K $47.36 Jun 13, 2025 By 401(k) Plan
Common Stock 7.69K $316K $41.08 Jun 16, 2025 Direct
Restricted Stock Units 0 $266K $26.53 Jun 13, 2025 Direct Common Stock
Stock Option (right to buy) 15.3K $168K $10.99 Mar 5, 2025 Direct Common Stock

Transactions reported by Elizabeth Yeu Lin for Tarsus Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.